These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Binding of 125I-endothelin-1 and 125I-endothelin-3 in rabbit saphenous vein: evidence for an atypical ET binding component. Liu EC; Monshizadegan H; Chao CC; Lynch J; Fisher SM; Rose PM; Webb ML J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S132-5. PubMed ID: 7509924 [TBL] [Abstract][Full Text] [Related]
28. Characterization of endothelin receptors in rat renal artery in vitro. Clark KL; Pierre L Br J Pharmacol; 1995 Feb; 114(4):785-90. PubMed ID: 7773538 [TBL] [Abstract][Full Text] [Related]
29. Endothelin ETA and ETB receptors mediate vascular smooth-muscle contraction. White DG; Cannon TR; Garratt H; Mundin JW; Sumner MJ; Watts IS J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S144-8. PubMed ID: 7509927 [TBL] [Abstract][Full Text] [Related]
30. Distribution of endothelin-1-receptor subtypes in rat portal vein. Filippelli A; Falciani M; Palla A; D'Amico M; Vacca C; Rossi F J Cardiovasc Pharmacol; 1996 Jan; 27(1):113-18. PubMed ID: 8656643 [TBL] [Abstract][Full Text] [Related]
31. The pharmacological properties of the peptide, endothelin. Eglen RM; Michel AD; Sharif NA; Swank SR; Whiting RL Br J Pharmacol; 1989 Aug; 97(4):1297-307. PubMed ID: 2551446 [TBL] [Abstract][Full Text] [Related]
32. Incomplete inhibition of endothelin-1 pressor effects by an endothelin ETA receptor antagonist. Bird JE; Waldron TL Eur J Pharmacol; 1993 Aug; 240(2-3):295-8. PubMed ID: 8243544 [TBL] [Abstract][Full Text] [Related]
33. Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist. Shibasaki M; Fujimori A; Takanashi M; Kusayama T; Tokioka T; Satoh Y; Okazaki T; Uchida W; Inagaki O; Yanagisawa I Eur J Pharmacol; 1997 Sep; 335(2-3):167-73. PubMed ID: 9369370 [TBL] [Abstract][Full Text] [Related]
35. Pharmacological characterization of YM598, an orally active and highly potent selective endothelin ET(A) receptor antagonist. Yuyama H; Sanagi M; Koakutsu A; Mori M; Fujimori A; Harada H; Sudoh K; Miyata K Eur J Pharmacol; 2003 Sep; 478(1):61-71. PubMed ID: 14555186 [TBL] [Abstract][Full Text] [Related]
36. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Li JS; Turgeon A; Schiffrin EL Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791 [TBL] [Abstract][Full Text] [Related]
37. Inhibitory and facilitatory presynaptic effects of endothelin on sympathetic cotransmission in the rat isolated tail artery. Mutafova-Yambolieva VN; Westfall DP Br J Pharmacol; 1998 Jan; 123(1):136-42. PubMed ID: 9484864 [TBL] [Abstract][Full Text] [Related]
38. Endothelium-dependent vascular activities of endothelin-like peptides in the isolated superior mesenteric arterial bed of the rat. Douglas SA; Hiley CR Br J Pharmacol; 1990 Sep; 101(1):81-8. PubMed ID: 2282471 [TBL] [Abstract][Full Text] [Related]
39. Role of endothelin B receptors in enhancing endothelium-dependent nitric oxide-mediated vascular relaxation during high salt diet. Giardina JB; Green GM; Rinewalt AN; Granger JP; Khalil RA Hypertension; 2001 Feb; 37(2 Pt 2):516-23. PubMed ID: 11230328 [TBL] [Abstract][Full Text] [Related]
40. Comparison of the contractile effects and binding kinetics of endothelin-1 and sarafotoxin S6b in rat isolated renal artery. Devadason PS; Henry PJ Br J Pharmacol; 1997 May; 121(2):253-63. PubMed ID: 9154335 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]